CZ20012435A3 - Sulfonamidy bis-aminokyselin obsahující N-koncově substituovanou benzylovou skupinu pouľitelné jako inhibitory HIV proteáz - Google Patents

Sulfonamidy bis-aminokyselin obsahující N-koncově substituovanou benzylovou skupinu pouľitelné jako inhibitory HIV proteáz Download PDF

Info

Publication number
CZ20012435A3
CZ20012435A3 CZ20012435A CZ20012435A CZ20012435A3 CZ 20012435 A3 CZ20012435 A3 CZ 20012435A3 CZ 20012435 A CZ20012435 A CZ 20012435A CZ 20012435 A CZ20012435 A CZ 20012435A CZ 20012435 A3 CZ20012435 A3 CZ 20012435A3
Authority
CZ
Czechia
Prior art keywords
compound
group
mmol
hiv
formula
Prior art date
Application number
CZ20012435A
Other languages
Czech (cs)
English (en)
Inventor
Robert F. Kaltenbach
George L. Trainor
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of CZ20012435A3 publication Critical patent/CZ20012435A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CZ20012435A 1999-01-13 2000-01-13 Sulfonamidy bis-aminokyselin obsahující N-koncově substituovanou benzylovou skupinu pouľitelné jako inhibitory HIV proteáz CZ20012435A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11574699P 1999-01-13 1999-01-13

Publications (1)

Publication Number Publication Date
CZ20012435A3 true CZ20012435A3 (cs) 2002-02-13

Family

ID=22363180

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012435A CZ20012435A3 (cs) 1999-01-13 2000-01-13 Sulfonamidy bis-aminokyselin obsahující N-koncově substituovanou benzylovou skupinu pouľitelné jako inhibitory HIV proteáz

Country Status (15)

Country Link
EP (1) EP1140983A1 (zh)
JP (1) JP2002536298A (zh)
KR (1) KR20010101478A (zh)
CN (1) CN1336934A (zh)
AU (1) AU2725700A (zh)
BR (1) BR0007854A (zh)
CA (1) CA2353088A1 (zh)
CZ (1) CZ20012435A3 (zh)
HU (1) HUP0105235A3 (zh)
IL (1) IL143763A0 (zh)
NO (1) NO20013338L (zh)
PL (1) PL349774A1 (zh)
SK (1) SK9522001A3 (zh)
TR (1) TR200102033T2 (zh)
WO (1) WO2000042060A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1188766A1 (en) 1995-03-10 2002-03-20 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US7339078B2 (en) 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US20020022659A1 (en) * 2000-07-19 2002-02-21 Harris Gregory D. Crystalline and salt forms of an HIV protease inhibitor
US6617310B2 (en) * 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
US20020022742A1 (en) * 2000-07-19 2002-02-21 Harris Gregory D. Salt forms of an HIV protease inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843946A (en) * 1992-08-25 1998-12-01 G.D. Searle & Co. α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Also Published As

Publication number Publication date
TR200102033T2 (tr) 2001-12-21
BR0007854A (pt) 2002-01-15
AU2725700A (en) 2000-08-01
JP2002536298A (ja) 2002-10-29
IL143763A0 (en) 2002-04-21
WO2000042060A1 (en) 2000-07-20
HUP0105235A3 (en) 2002-08-28
EP1140983A1 (en) 2001-10-10
PL349774A1 (en) 2002-09-09
NO20013338L (no) 2001-09-13
CA2353088A1 (en) 2000-07-20
KR20010101478A (ko) 2001-11-14
CN1336934A (zh) 2002-02-20
HUP0105235A2 (hu) 2002-04-29
SK9522001A3 (en) 2002-03-05
NO20013338D0 (no) 2001-07-05

Similar Documents

Publication Publication Date Title
JP2004532224A (ja) Ｈｉｖ逆転写酵素阻害剤として有用な三環系化合物
CZ20012435A3 (cs) Sulfonamidy bis-aminokyselin obsahující N-koncově substituovanou benzylovou skupinu pouľitelné jako inhibitory HIV proteáz
US6391919B1 (en) Bis-amino acid sulfonamides containing substituted benzyl amines HIV protease inhibitors
EP0937067B1 (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
US6562848B1 (en) Bis-amino acid sulfonamides as HIV protease inhibitors
US6218386B1 (en) A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
AU722489B2 (en) (4r,5s,6s,7r)-hexahydro-1- {5-(3-aminoinazole)methyl} -3-butyl-5,6-dihydr oxy-4,7-bis {phaenylmethyl} -2h-1,3-diazepin-2-one, its preparation and its use as HIV protease inhibitor
US6313110B1 (en) Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
US6943170B2 (en) N-cycloalkylglycines as HIV protease inhibitors
US5932570A (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
US20020022742A1 (en) Salt forms of an HIV protease inhibitor
MXPA01007047A (en) Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
US7015214B2 (en) Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors
US20060128634A1 (en) Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
US20020022659A1 (en) Crystalline and salt forms of an HIV protease inhibitor
MXPA99004294A (en) (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl]-3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
HRP970595A2 (en) 1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a hiv proteaze inhibitor
HRP970586A2 (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
MXPA99004286A (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors